XTX Topco »

Gain Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-09-30 $96k 54k 1.77

More positions owned by XTX Topco

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Cme (CME)
Thermo Fisher Scientific (TMO)
Cisco Systems (CSCO)
Bristol Myers Squibb (BMY)
Enbridge (ENB)
American Tower Reit (AMT)
Us Bancorp Del Com New (USB)
American Intl Group Com New (AIG)
TJX Companies (TJX)
Southern Company (SO)
Stellantis SHS (STLA)
Ares Management Corporation Cl A Com Stk (ARES)

View all positions for XTX Topco

Top funds holding Gain Therapeutics

Jones Financial Companies, L.L
DME Capital Management
Vanguard Group
Citadel Advisors
Geode Capital Management
Cambridge Investment Research Advisors
Marshall Wace
UBS Group
Renaissance Technologies
BlackRock
State Street Corporation
Northern Trust
Susquehanna International
Morgan Stanley
Jane Street

View all funds holding Gain Therapeutics